Haemonetics "Whole Blood" business Acquisition
Home
Corporate GVS Announces Strategic Acquisition of Haemonetics’ Whole Blood Business
-
MedTech
Precision solution for life-saving technology
Advanced Medical Technologies for Global Health.MEDTECH PRODUCTS CATALOG
-
Transfusion Medicine
Blood solutions for saving lives
Empowering Global Blood Safety Through Innovation, Precision, and Trust.TRANSFUSION MEDICINE PRODUCTS CATALOG
-
Life Sciences
Powering research, providing results
Microfiltration technologies for biology, chemistry, diagnostics, and bioprocessing.LIFE SCIENCES PRODUCTS CATALOG
-
Safety
Protecting you for life's best moments
High-performance devices for protection in the workplace.SAFETY PRODUCTS CATALOG -
Energy & Mobility
Driven by innovation
Advanced filtration for energy systems and sustainable mobility.E & M PRODUCTS CATALOG
-
-
ESG
COMPANYOur commitment to a Sustainable Future
-
GVS: IPO Ceremony at Borsa Italiana
CorporateWatch the video of a special moment: our debut on the Italian Stock Exchange!
News & media
-
GVS acquires 100% of the Italian Group Haemotronic
GVS has acquired the 100% of the share capital of the Italian Group Haemotronic. -
GVS refunds the original loan of 90 million Euros in advance
The Group will refund the residual amount of the loan stipulated in 2017 by 21 October 2020 -
GVS debuts on Borsa Italiana's MTA
First listing of the year on the Mercato Telematico Azionario (MTA) of the Italian Stock Exchange -
GVS acquires 100% of the RPB Group
GVS has acquired the 100% of the share capital of the RPB Group.
Divisions